Catalyst event

Astrazeneca PLC (AZN)

From KEDI U.S. Medical AI Index (KUSMAI)

H1 and Q2 2026 earnings results scheduled to be released. A low impact is estimated as this is a routine financial disclosure scheduled.

Korean translation

2026년 상반기 및 2분기 실적 발표 예정됨. 정기적인 실적 공시이므로 낮은 영향이 예상됨.